Combination Trans Arterial Chemoembolization (TACE) Plus Sorafenib for the Management of Unresectable Hepatocellular Carcinoma: A Systematic Review of the Literature

Sorafenib combined with transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma: a large-scale multicenter study of 222 patients

(2013) Y. Zhao et al.   ANNALS OF ONCOLOGY

Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: A propensity score matching study

(2013) Wei Bai et al.   Journal of Digestive Diseases

Transplantation for Hepatocellular Carcinoma in Younger Patients Has an Equivocal Survival Advantage as Compared With Resection

(2013) J.A. Graham et al.   TRANSPLANTATION PROCEEDINGS

The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma

(2012) Xu-Dong Qu et al.   BMC CANCER

Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study

(2012) Wolfgang Sieghart et al.   EUROPEAN RADIOLOGY

Interim analysis of START: Study in asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial

(2012) Young-Hwa Chung et al.   INTERNATIONAL JOURNAL OF CANCER

Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma

(2012) Joong-Won Park et al.   JOURNAL OF HEPATOLOGY

Transarterial Chemoembolization Plus Sorafenib: A Sequential Therapeutic Scheme for HCV-Related Intermediate-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial

(2012) D. Sansonno et al.   ONCOLOGIST

The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma

(2011) R. Cabrera et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma

(2011) Masatoshi Kudo et al.   EUROPEAN JOURNAL OF CANCER

Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma

(2011) Timothy M. Pawlik et al.   JOURNAL OF CLINICAL ONCOLOGY

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization

(2010) J.-L. Raoul et al.   CANCER TREATMENT REVIEWS

Continuous Administration of Sorafenib in Combination with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: Results of a Phase I Study

(2010) J.-F. Dufour et al.   ONCOLOGIST

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evolution of systemic therapy of advanced hepatocellular carcinoma

(2008) Thomas Yau et al.   WORLD JOURNAL OF GASTROENTEROLOGY